secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mural Oncology plc (—)
CIK:        0001971543
Form:       8-K
Filed at:   2024-09-23T23:59:59+00:00
Accession:  0000950170-24-108626
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Mural Oncology appoints Sachiyo Minegishi as independent director and Audit Committee chair
--------------------------------------------------------------------------------

- Appointed as director effective Sept 20, 2024; initial term through 2025 AGM.
- Also named Chair of Audit Committee and member of Nominating & Corporate Governance Committee.
- Received option for 15,335 ordinary shares at $3.38 (closing price), vesting quarterly over 3 years.
- Annual cash compensation of $40,000 plus additional committee fees and equity grants.
- Determined independent under Nasdaq rules; no family relationships or transactions with company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1971543/000095017024108626/0000950170-24-108626-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1971543/000095017024108626/mura-20240920.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-108626

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer